Headline
The latest stories from AHA Today.
The AHA today released its latest edition of the COVID-19 Snapshot underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency. The COVID-19 Snapshot combines important data points with news articles and testimonials from the field to…
The Federal Emergency Management Agency today published a plan of action to develop a national strategy that would coordinate transportation systems needed to supply, produce and distribute critical COVID-19 health care resources, the latest addition to a 2020 voluntary agreement under the Defense…
The Centers for Medicare & Medicaid Services yesterday released for comment its advance notice of methodological changes to Medicare Advantage capitation rates and Part C and Part D payment policies for calendar year 2023.
Registration is now open for the 2022 Accelerating Health Equity Conference, an in-person event in Cleveland.
In a statement submitted to House and Senate subcommittee hearings on fraud, price gouging and corporate profiteering during the COVID-19 pandemic, the AHA urged Congress to examine reports of anticompetitive conduct by travel staffing agencies and coordinate with the Federal Trade Commission and…
While intentional drug overdoses have declined overall in the United States, they have increased among young people, the elderly and Black women, according to study by the National Institute on Drug Abuse published today in the American Journal of Psychiatry.
The Department of Health and Human Services has extended to Feb. 18 the deadline for health care organizations to register for the first phase of its Racial Equity in Postpartum Care Challenge, which will recognize effective programs to address equity in postpartum care for Black and Native women…
The AHA has released a guide to help health care governing boards work with their organization’s leadership team to set cybersecurity priorities and reduce cyber risks.
As part of AHA’s Joining Hands for Greater Impact series, Priya Bathija, AHA vice president of strategic initiatives, speaks with Rita Carreon, vice president for health at UnidosUS, about how to overcome barriers to vaccine confidence and access in the Latino community.
The Food and Drug Administration announced a Class 1 recall of two COVID-19 tests the agency had not authorized or approved.